Antihypertensive power of Naringenin is mediated via attenuation of mineralocorticoid receptor (MCR)/ angiotensin converting enzyme (ACE)/ kidney injury molecule (Kim-1) signaling pathway

dc.contributor.authorOyagbemi, Ademola Adetokunbo
dc.contributor.authorOmobowale, Temidayo Olutayo
dc.contributor.authorAdejumobi, Olumuyiwa Abiola
dc.contributor.authorOwolabi, Abiodun Mary
dc.contributor.authorOgunpolu, Blessing Seun
dc.contributor.authorFalayi, Olufunke Olubunmi
dc.contributor.authorHassan, Fasilat Oluwakemi
dc.contributor.authorOgunmiluyi, Iyanuoluwa Omolola
dc.contributor.authorAsenuga, Ebunoluwa Racheal
dc.contributor.authorOla-Davies, Olufunke Eunice
dc.contributor.authorSoetan, Kehinde Olugboyega
dc.contributor.authorSaba, Adebowale Benard
dc.contributor.authorAdedapo, Adeolu Alex
dc.contributor.authorNkadimeng, Sanah Malomile
dc.contributor.authorMcGaw, Lyndy Joy
dc.contributor.authorOguntibeju, Oluwafemi Omoniyi
dc.contributor.authorYakubu, Momoh Audu
dc.date.accessioned2023-10-31T08:49:22Z
dc.date.available2023-10-31T08:49:22Z
dc.date.issued2020-08
dc.description.abstractPlease read abstract in the article.en_US
dc.description.departmentParaclinical Sciencesen_US
dc.description.librarianhj2023en_US
dc.description.sponsorshipCape Peninsula University of Technology and National Research Foundation (South Africa).en_US
dc.description.urihttps://www.elsevier.com/locate/ejpharen_US
dc.identifier.citationOyagbemi, A.A., Omobowale, T.O., Adejumobi, O.A. et al. 2020, 'Antihypertensive power of Naringenin is mediated via attenuation of mineralocorticoid receptor (MCR)/ angiotensin converting enzyme (ACE)/ kidney injury molecule (Kim-1) signaling pathway', European Journal of Pharmacology, vol. 880, art. 173142, pp. 1-13, doi : 10.1016/j.ejphar.2020.173142.en_US
dc.identifier.issn0014-2999 (print)
dc.identifier.issn1879-0712 (online)
dc.identifier.other10.1016/j.ejphar.2020.173142
dc.identifier.urihttp://hdl.handle.net/2263/93122
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.rights© 2020 Elsevier B.V. All rights reserved. Notice : this is the author’s version of a work that was accepted for publication in European Journal of Pharmacology. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. A definitive version was subsequently published in European Journal of Pharmacology, vol. 880, art. 173142, pp. 1-13, doi : 10.1016/j.ejphar.2020.173142.en_US
dc.subjectHypertension (HTN)en_US
dc.subjectOxidative stressen_US
dc.subjectNaringeninen_US
dc.subjectNovel-antihypertensive agenten_US
dc.subjectSDG-03: Good health and well-beingen_US
dc.subjectAntihypertensive poweren_US
dc.subjectMineralocorticoid receptor (MCR)en_US
dc.subjectAngiotensin converting enzyme (ACE)en_US
dc.subjectKidney injury molecule (Kim-1)en_US
dc.titleAntihypertensive power of Naringenin is mediated via attenuation of mineralocorticoid receptor (MCR)/ angiotensin converting enzyme (ACE)/ kidney injury molecule (Kim-1) signaling pathwayen_US
dc.typePostprint Articleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Oyagbemi_Antihypertensive_2020.pdf
Size:
2.86 MB
Format:
Adobe Portable Document Format
Description:
Postprint Article
Download

License bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Research Articles (Paraclinical Sciences)
Research Articles (University of Pretoria)
Simple item page